Subtopic Deep Dive

Photodynamic Therapy with Nanoparticles
Research Guide

What is Photodynamic Therapy with Nanoparticles?

Photodynamic therapy with nanoparticles uses nanoparticle-photosensitizer conjugates to enhance reactive oxygen species generation, improve oxygen delivery, and enable deep-tissue treatment in cancer theranostics.

Nanoparticles such as upconversion nanoparticles and gold nanoparticles address PDT limitations like hypoxia and shallow penetration. Research focuses on conjugates for targeted ROS production and tumor microenvironment modulation. Over 50 papers from 2007-2021 cover these advances, with Agostinis et al. (2011) cited 5032 times.

15
Curated Papers
3
Key Challenges

Why It Matters

Nano-enhanced PDT treats resistant tumors by overcoming hypoxia, as shown in Jing et al. (2019) on tumor microenvironment regulation. Gold nanoparticles enable plasmonic effects for deeper light penetration (Huang et al., 2007; Dykman and Khlebtsov, 2011). Upconversion nanoparticles allow near-infrared activation for in vivo therapy (Idris et al., 2012), improving clinical outcomes in solid tumors.

Key Research Challenges

Hypoxia in tumor microenvironment

Tumor hypoxia limits ROS generation in PDT due to low oxygen levels. Jing et al. (2019) highlight hypoxia's role in therapy resistance. Nanoparticles must deliver oxygen or alleviate hypoxia for efficacy.

Shallow tissue penetration

Traditional PDT uses visible light with poor deep-tissue reach. Upconversion nanoparticles convert NIR to visible light (Idris et al., 2012). Plasmonic gold nanoparticles enhance light absorption (Huang et al., 2007).

Photosensitizer stability and delivery

Photosensitizers suffer photobleaching and poor tumor targeting. Graphene quantum dots improve singlet oxygen yield and biocompatibility (Ge et al., 2014). Conjugates with nanoparticles boost stability (Abrahamse and Hamblin, 2016).

Essential Papers

1.

Photodynamic therapy of cancer: An update

Patrizia Agostinis, Kristian Berg, Keith A. Cengel et al. · 2011 · CA A Cancer Journal for Clinicians · 5.0K citations

Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic procedure that can exert a selective cytotoxic activity toward malignant cells. The procedure involves administra...

2.

Plasmonic photothermal therapy (PPTT) using gold nanoparticles

Xiaohua Huang, Prashant K. Jain, Ivan H. El‐Sayed et al. · 2007 · Lasers in Medical Science · 2.3K citations

3.

ROS in cancer therapy: the bright side of the moon

Bruno Perillo, Marzia Di Donato, Antonio Pezone et al. · 2020 · Experimental & Molecular Medicine · 2.0K citations

4.

Photodynamic therapy – mechanisms, photosensitizers and combinations

Stanisław Kwiatkowski, Bartosz Knap, Dawid Przystupski et al. · 2018 · Biomedicine & Pharmacotherapy · 2.0K citations

5.

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Xinming Jing, Fengming Yang, Chuchu Shao et al. · 2019 · Molecular Cancer · 2.0K citations

6.

New photosensitizers for photodynamic therapy

Heidi Abrahamse, Michael R. Hamblin · 2016 · Biochemical Journal · 1.9K citations

Photodynamic therapy (PDT) was discovered more than 100 years ago, and has since become a well-studied therapy for cancer and various non-malignant diseases including infections. PDT uses photosens...

7.

Gold nanoparticles in biomedical applications: recent advances and perspectives

Л. А. Дыкман, Nikolai G. Khlebtsov · 2011 · Chemical Society Reviews · 1.9K citations

Gold nanoparticles (GNPs) with controlled geometrical, optical, and surface chemical properties are the subject of intensive studies and applications in biology and medicine. To date, the ever incr...

Reading Guide

Foundational Papers

Start with Agostinis et al. (2011, 5032 citations) for PDT mechanisms, then Huang et al. (2007, 2302 citations) for gold nanoparticles, and Dykman and Khlebtsov (2011, 1880 citations) for biomedical applications.

Recent Advances

Study Abrahamse and Hamblin (2016) for new photosensitizers, Jing et al. (2019) for hypoxia, and Herrmann et al. (2021) for extracellular vesicle delivery platforms.

Core Methods

Core techniques: photosensitizer conjugation to upconversion nanoparticles (Idris et al., 2012), plasmonic photothermal synergy (Huang et al., 2007), and high-yield quantum dots (Ge et al., 2014).

How PapersFlow Helps You Research Photodynamic Therapy with Nanoparticles

Discover & Search

Research Agent uses searchPapers for 'nanoparticle photodynamic therapy cancer' to find Agostinis et al. (2011, 5032 citations), then citationGraph reveals Idris et al. (2012) on upconversion nanoparticles, and findSimilarPapers expands to hypoxia-related works like Jing et al. (2019). exaSearch uncovers niche conjugates from 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent to extract ROS mechanisms from Kwiatkowski et al. (2018), verifies claims with verifyResponse (CoVe) against Perillo et al. (2020) on ROS in cancer, and runs PythonAnalysis to plot citation trends or simulate oxygen diffusion models using NumPy, with GRADE scoring evidence strength for nanoparticle efficacy.

Synthesize & Write

Synthesis Agent detects gaps in hypoxia alleviation post-Jing et al. (2019), flags contradictions between plasmonic (Huang et al., 2007) and upconversion (Idris et al., 2012) approaches, then Writing Agent uses latexEditText for manuscript drafting, latexSyncCitations for 10+ papers, and latexCompile for PDF output; exportMermaid visualizes PDT-nanoparticle mechanism diagrams.

Use Cases

"Model ROS generation rates from nanoparticle-PDT papers using Python"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted data from Ge et al. 2014) → plot of singlet oxygen yields vs. nanoparticle type.

"Draft LaTeX review on upconversion nanoparticles in PDT"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Idris et al. 2012 et al.) + latexCompile → camera-ready LaTeX review section with figures.

"Find GitHub code for nanoparticle PDT simulations"

Research Agent → paperExtractUrls (from Huang et al. 2007 cites) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified simulation code for plasmonic effects.

Automated Workflows

Deep Research workflow scans 50+ papers on nanoparticle PDT, chaining searchPapers → citationGraph → structured report on ROS enhancement since Agostinis et al. (2011). DeepScan applies 7-step analysis with CoVe checkpoints to verify hypoxia strategies in Jing et al. (2019). Theorizer generates hypotheses on gold-upconversion hybrids from Dykman (2011) and Idris (2012).

Frequently Asked Questions

What defines photodynamic therapy with nanoparticles?

It involves nanoparticle-photosensitizer conjugates for enhanced ROS generation, oxygen delivery, and deep-tissue PDT in cancer, as in upconversion systems (Idris et al., 2012).

What are key methods in nanoparticle PDT?

Methods include upconversion for NIR activation (Idris et al., 2012), plasmonic enhancement with gold nanoparticles (Huang et al., 2007), and graphene quantum dots for high singlet oxygen (Ge et al., 2014).

What are major papers on this topic?

Agostinis et al. (2011, 5032 citations) updates PDT mechanisms; Huang et al. (2007, 2302 citations) covers gold nanoparticle photothermal synergy; Idris et al. (2012, 1430 citations) demonstrates in vivo upconversion PDT.

What open problems exist in nanoparticle PDT?

Challenges include scalable oxygen delivery under hypoxia (Jing et al., 2019) and clinical translation of conjugates beyond lab models (Abrahamse and Hamblin, 2016).

Research Nanoplatforms for cancer theranostics with AI

PapersFlow provides specialized AI tools for Engineering researchers. Here are the most relevant for this topic:

See how researchers in Engineering use PapersFlow

Field-specific workflows, example queries, and use cases.

Engineering Guide

Start Researching Photodynamic Therapy with Nanoparticles with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Engineering researchers